1.
Patard JJ, Rodriguez A, Rioux-Leclercq N, et al (2002) Prognostic significance of the mode of
detection in renal tumours. BJU Int 90:358–363. https://doi.org/10.1046/j.1464-410X.2002.02910.x
2.
Dudani S, De Velasco G, Wells JC, et al (2021) Evaluation of Clear Cell, Papillary, and Chromophobe
Renal Cell Carcinoma Metastasis Sites and Association with Survival. JAMA Netw Open 4:.
https://doi.org/10.1001/JAMANETWORKOPEN.2020.21869
3.
Metastases. In Vivo 34:675–678
4.
10
11
Woodward E, Jagdev S, McParland L, et al (2011) Skeletal complications and survival in renal cancer
patients with bone metastases. Bone 48:160–166. https://doi.org/10.1016/j.bone.2010.09.008
5.
12
13
Nieder C, Dalhaug A PA (2020) Management of Patients With Metastatic Renal Cell Cancer and Bone
Santini D, Procopio G, Porta C, et al Natural History of Malignant Bone Disease in Renal Cancer: Final
Results of an Italian Bone Metastasis Survey. https://doi.org/10.1371/journal.pone.0083026
6.
Hara H, Sakai Y, Kawamoto T, et al (2021) Surgical outcomes of metastatic bone tumors in the
14
extremities (Surgical outcomes of bone metastases). J Bone Oncol 27:100352.
15
https://doi.org/10.1016/j.jbo.2021.100352
16
7.
17
18
with skeletal metastasis. Cancer Med 3:1359–1367. https://doi.org/10.1002/cam4.292
8.
19
20
9.
10.
Evenski A, Ramasunder S, Fox W, et al (2012) Treatment and survival of osseous renal cell carcinoma
metastases. J Surg Oncol 106:850–855. https://doi.org/10.1002/jso.23134
11.
25
26
Kanda Y (2013) Investigation of the freely available easy-to-use software “EZR” for medical statistics.
Bone Marrow Transplant 48:452–458. https://doi.org/10.1038/bmt.2012.244
23
24
Motzer BRJ, Bacik J, Murphy BA, et al (2002) Interferon-Alfa as a Comparative Treatment for
Clinical. J Clin Oncol 20:289–296
21
22
Katagiri H, Okada R, Takagi T, et al (2014) New prognostic factors and scoring system for patients
Lin PP, Mirza AN, Lewis VO, et al (2007) Patient survival after surgery for osseous metastases from
renal cell carcinoma. J Bone Jt Surg - Ser A 89:1794–1801. https://doi.org/10.2106/JBJS.F.00603
12.
Szendrői A, Dinya E, Kardos M, et al (2010) Prognostic factors and survival of renal clear cell
27
carcinoma patients with bone metastases. Pathol Oncol Res 16:29–38. https://doi.org/10.1007/s12253-
28
009-9184-7
29
30
13.
Zołnierek J (2010) Efficacy of targeted therapy in patients with renal cell carcinoma with pre-existing
or new bone metastases. 371–378. https://doi.org/10.1007/s00432-009-0664-7
16
14.
Fottner A, Szalantzy M, Wirthmann L, et al (2010) Bone metastases from renal cell carcinoma: Patient
survival after surgical treatment. BMC Musculoskelet Disord 11:2–7. https://doi.org/10.1186/1471-
2474-11-145
15.
Hwang N, Nandra R, Grimer RJ, et al (2014) Massive endoprosthetic replacement for bone metastases
resulting from renal cell carcinoma: Factors influencing patient survival. Eur J Surg Oncol 40:429–434.
https://doi.org/10.1016/j.ejso.2013.08.001
16.
Dong Y, Wang Z, Lu X, Wu Z, Zhang Z, Yu Y, Peng F, Liu B WL (2020) Clinical outcomes of 168
Chinese patients after local surgery for bone metastases arising from advanced renal cell carcinoma.
Cancer 2079-2085.
10
17.
Park BJ, Seaman SC, Noeller JL, et al (2021) Metastatic Renal Cell Carcinoma to the Spine: Outcomes
11
and Morbidity: Single-Center Experience. World Neurosurg 154:e398–e405.
12
https://doi.org/10.1016/j.wneu.2021.07.041
13
18.
Higuchi T, Yamamoto N, Hayashi K, et al (2018) The efficacy of wide resection for musculoskeletal
14
metastatic lesions of renal cell carcinoma. Anticancer Res 38:577–582.
15
https://doi.org/10.21873/anticanres.12262
16
19.
Langerhuizen DWG, Janssen SJ, van der Vliet QMJ, et al (2016) Metastasectomy, intralesional
17
resection, or stabilization only in the treatment of bone metastases from renal cell carcinoma. J Surg
18
Oncol 114:237–245. https://doi.org/10.1002/jso.24284
19
17
...
論文の公開元へ
